Cathie Wood's position in Veracyte is currently worth $108 Million. That's 0.84% of their equity portfolio (29th largest holding). The investor owns 5.02% of the outstanding Veracyte stock. The first Veracyte trade was made in Q4 2016. Since then Cathie Wood bought shares eighteen more times and sold shares on thirteen occasions. The stake costed the investor $103 Million, netting the investor a gain of 4.2% so far.